<qa>  What is the Phase 3b study designed to define better therapeutic use of IFN-gammStudy GIPF-003 is a Phase 3b study designed to define better therapeutic use of IFN-gamma 1b in patients wtih IPF. The study will be conducted primarily in Europe and will enroll 210 patients. 